Thermo Fisher Scientific Inc.
US ˙ NYSE ˙ US8835561023

SecurityTMO / Thermo Fisher Scientific Inc.
InsiderKeith R. Alexandra
This page shows the track record and history of Keith R. Alexandra insider trades in Thermo Fisher Scientific Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Keith R. Alexandra in TMO / Thermo Fisher Scientific Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TMO / Thermo Fisher Scientific Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Keith R. Alexandra in TMO / Thermo Fisher Scientific Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TMO / Thermo Fisher Scientific Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-05-22 2025-05-21 4 Keith R. Alexandra TMO Common Stock A - Award D 565 2,103
2024-05-23 2024-05-22 4 Keith R. Alexandra TMO Common Stock A - Award D 339 1,538
2023-05-26 2023-05-24 4 Keith R. Alexandra TMO Common Stock A - Award D 392 1,199
2022-05-20 2022-05-18 4 Keith R. Alexandra TMO Common Stock A - Award D 369 807
2022-04-05 2022-04-02 4 Keith R. Alexandra TMO Phantom Stock Units A - Award D 53 313
2022-01-04 2021-12-31 4 Keith R. Alexandra TMO Phantom Stock Units A - Award D 47 260
2021-10-05 2021-10-02 4 Keith R. Alexandra TMO Phantom Stock Units A - Award D 55 213
2021-07-07 2021-07-03 4 Keith R. Alexandra TMO Phantom Stock Units A - Award D 61 159
2021-05-20 2021-05-19 4 Keith R. Alexandra TMO Common Stock A - Award D 438 438
2021-04-06 2021-04-03 4 Keith R. Alexandra TMO Phantom Stock Units A - Award D 68 98
2021-01-05 2020-12-31 4 Keith R. Alexandra TMO Phantom Stock Units A - Award D 29 29
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)